| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 7e-09 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |